ANTICORPOS CONTRA KLK5
ANTICORPOS CONTRA KLK5. A presente invenção se refere a anticorpos que ligam e inibem KLK5 e métodos de usar os mesmos para tratar doenças causadas pelo desequilíbrio de KLK5. Em particular, a presente invenção se refere a anticorpos inibidores da ligação de KLK5 e seu uso no tratamento da doença de...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NEESHA DEDI DAVID JAMES MCMILLAN ALISON TURNER SEAN MASON NICCOLO PENGO SEPPE FRANS ROMAN LEYSEN MARTIN ANTHONY REDHEAD GILLIAN CLAIRE NESS PETER CHARLES ELLIOTT KERRY LOUISE TYSON |
| description | ANTICORPOS CONTRA KLK5. A presente invenção se refere a anticorpos que ligam e inibem KLK5 e métodos de usar os mesmos para tratar doenças causadas pelo desequilíbrio de KLK5. Em particular, a presente invenção se refere a anticorpos inibidores da ligação de KLK5 e seu uso no tratamento da doença de Netherton, dermatite atópica e câncer.
The present invention relates to antibodies which bind and inhibit KLK5 and methods of using the same to treat diseases caused by KLK5 imbalance. In particular, the present invention relates to inhibitory anti-KLK5 antibodies and their use in the treatment of Netherton disease, atopic dermatitis and cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112022015281A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112022015281A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112022015281A23</originalsourceid><addsrcrecordid>eNrjZBBz9AvxdPYPCvAPVnD29wsJclTw9vE25WFgTUvMKU7lhdLcDKpuriHOHrqpBfnxqcUFicmpeakl8U5BhoZGBkZGBoamRhaGjkbGxKoDAKY8IKE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICORPOS CONTRA KLK5</title><source>esp@cenet</source><creator>NEESHA DEDI ; DAVID JAMES MCMILLAN ; ALISON TURNER ; SEAN MASON ; NICCOLO PENGO ; SEPPE FRANS ROMAN LEYSEN ; MARTIN ANTHONY REDHEAD ; GILLIAN CLAIRE NESS ; PETER CHARLES ELLIOTT ; KERRY LOUISE TYSON</creator><creatorcontrib>NEESHA DEDI ; DAVID JAMES MCMILLAN ; ALISON TURNER ; SEAN MASON ; NICCOLO PENGO ; SEPPE FRANS ROMAN LEYSEN ; MARTIN ANTHONY REDHEAD ; GILLIAN CLAIRE NESS ; PETER CHARLES ELLIOTT ; KERRY LOUISE TYSON</creatorcontrib><description>ANTICORPOS CONTRA KLK5. A presente invenção se refere a anticorpos que ligam e inibem KLK5 e métodos de usar os mesmos para tratar doenças causadas pelo desequilíbrio de KLK5. Em particular, a presente invenção se refere a anticorpos inibidores da ligação de KLK5 e seu uso no tratamento da doença de Netherton, dermatite atópica e câncer.
The present invention relates to antibodies which bind and inhibit KLK5 and methods of using the same to treat diseases caused by KLK5 imbalance. In particular, the present invention relates to inhibitory anti-KLK5 antibodies and their use in the treatment of Netherton disease, atopic dermatitis and cancer.</description><language>por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220920&DB=EPODOC&CC=BR&NR=112022015281A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220920&DB=EPODOC&CC=BR&NR=112022015281A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NEESHA DEDI</creatorcontrib><creatorcontrib>DAVID JAMES MCMILLAN</creatorcontrib><creatorcontrib>ALISON TURNER</creatorcontrib><creatorcontrib>SEAN MASON</creatorcontrib><creatorcontrib>NICCOLO PENGO</creatorcontrib><creatorcontrib>SEPPE FRANS ROMAN LEYSEN</creatorcontrib><creatorcontrib>MARTIN ANTHONY REDHEAD</creatorcontrib><creatorcontrib>GILLIAN CLAIRE NESS</creatorcontrib><creatorcontrib>PETER CHARLES ELLIOTT</creatorcontrib><creatorcontrib>KERRY LOUISE TYSON</creatorcontrib><title>ANTICORPOS CONTRA KLK5</title><description>ANTICORPOS CONTRA KLK5. A presente invenção se refere a anticorpos que ligam e inibem KLK5 e métodos de usar os mesmos para tratar doenças causadas pelo desequilíbrio de KLK5. Em particular, a presente invenção se refere a anticorpos inibidores da ligação de KLK5 e seu uso no tratamento da doença de Netherton, dermatite atópica e câncer.
The present invention relates to antibodies which bind and inhibit KLK5 and methods of using the same to treat diseases caused by KLK5 imbalance. In particular, the present invention relates to inhibitory anti-KLK5 antibodies and their use in the treatment of Netherton disease, atopic dermatitis and cancer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBz9AvxdPYPCvAPVnD29wsJclTw9vE25WFgTUvMKU7lhdLcDKpuriHOHrqpBfnxqcUFicmpeakl8U5BhoZGBkZGBoamRhaGjkbGxKoDAKY8IKE</recordid><startdate>20220920</startdate><enddate>20220920</enddate><creator>NEESHA DEDI</creator><creator>DAVID JAMES MCMILLAN</creator><creator>ALISON TURNER</creator><creator>SEAN MASON</creator><creator>NICCOLO PENGO</creator><creator>SEPPE FRANS ROMAN LEYSEN</creator><creator>MARTIN ANTHONY REDHEAD</creator><creator>GILLIAN CLAIRE NESS</creator><creator>PETER CHARLES ELLIOTT</creator><creator>KERRY LOUISE TYSON</creator><scope>EVB</scope></search><sort><creationdate>20220920</creationdate><title>ANTICORPOS CONTRA KLK5</title><author>NEESHA DEDI ; DAVID JAMES MCMILLAN ; ALISON TURNER ; SEAN MASON ; NICCOLO PENGO ; SEPPE FRANS ROMAN LEYSEN ; MARTIN ANTHONY REDHEAD ; GILLIAN CLAIRE NESS ; PETER CHARLES ELLIOTT ; KERRY LOUISE TYSON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112022015281A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NEESHA DEDI</creatorcontrib><creatorcontrib>DAVID JAMES MCMILLAN</creatorcontrib><creatorcontrib>ALISON TURNER</creatorcontrib><creatorcontrib>SEAN MASON</creatorcontrib><creatorcontrib>NICCOLO PENGO</creatorcontrib><creatorcontrib>SEPPE FRANS ROMAN LEYSEN</creatorcontrib><creatorcontrib>MARTIN ANTHONY REDHEAD</creatorcontrib><creatorcontrib>GILLIAN CLAIRE NESS</creatorcontrib><creatorcontrib>PETER CHARLES ELLIOTT</creatorcontrib><creatorcontrib>KERRY LOUISE TYSON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NEESHA DEDI</au><au>DAVID JAMES MCMILLAN</au><au>ALISON TURNER</au><au>SEAN MASON</au><au>NICCOLO PENGO</au><au>SEPPE FRANS ROMAN LEYSEN</au><au>MARTIN ANTHONY REDHEAD</au><au>GILLIAN CLAIRE NESS</au><au>PETER CHARLES ELLIOTT</au><au>KERRY LOUISE TYSON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICORPOS CONTRA KLK5</title><date>2022-09-20</date><risdate>2022</risdate><abstract>ANTICORPOS CONTRA KLK5. A presente invenção se refere a anticorpos que ligam e inibem KLK5 e métodos de usar os mesmos para tratar doenças causadas pelo desequilíbrio de KLK5. Em particular, a presente invenção se refere a anticorpos inibidores da ligação de KLK5 e seu uso no tratamento da doença de Netherton, dermatite atópica e câncer.
The present invention relates to antibodies which bind and inhibit KLK5 and methods of using the same to treat diseases caused by KLK5 imbalance. In particular, the present invention relates to inhibitory anti-KLK5 antibodies and their use in the treatment of Netherton disease, atopic dermatitis and cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112022015281A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANTICORPOS CONTRA KLK5 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A15%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NEESHA%20DEDI&rft.date=2022-09-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112022015281A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |